Toileting at Night in Older Adults: Light to Maximize Balance, Minimize Insomnia
NCT ID: NCT01350505
Last Updated: 2019-02-15
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
21 participants
INTERVENTIONAL
2013-10-15
2017-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Individually Tailored Lighting System to Improve Sleep in Older Adults
NCT01855126
The Long-term Impact of a Light Intervention on Sleep and Cognition in Mild Cognitive Impairment
NCT04073628
Investigating the Impact of Duration and Amount of Light on the Circadian System Response - Aim 3
NCT06595030
Bright Light Therapy in Older Adults With Moderate to Very Severe Dementia
NCT04949984
Light Treatment for Sleep/Wake Disturbances in Alzheimer's Disease
NCT00946530
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CROSSOVER
BASIC_SCIENCE
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
All subjects
13 minutes of light at night (2 hours after bedtime)
White light exposure
\~200 lux of broad spectrum white light
Dim white light exposure
\~28 lux of broad spectrum white light
Very dim white light exposure
\<0.5 lux of broad spectrum white light
Dim orange light exposure
\~28 lux of orange light
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
White light exposure
\~200 lux of broad spectrum white light
Dim white light exposure
\~28 lux of broad spectrum white light
Very dim white light exposure
\<0.5 lux of broad spectrum white light
Dim orange light exposure
\~28 lux of orange light
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Stable health
* Normal color vision
Exclusion Criteria
* Depression
* Sleep disorders
* Smoking
* Use of illegal drugs
55 Years
85 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
VA Office of Research and Development
FED
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jamie M Zeitzer, PhD
Role: PRINCIPAL_INVESTIGATOR
VA Palo Alto Health Care System, Palo Alto, CA
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
VA Palo Alto Health Care System, Palo Alto, CA
Palo Alto, California, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
McBean AL, Najjar RP, Schuchard RA, Hall CD, Wang CA, Ku B, Zeitzer JM. Standing Balance and Spatiotemporal Aspects of Gait Are Impaired Upon Nocturnal Awakening in Healthy Late Middle-Aged and Older Adults. J Clin Sleep Med. 2016 Nov 15;12(11):1477-1486. doi: 10.5664/jcsm.6270.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol
Document Type: Statistical Analysis Plan
Document Type: Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
E0773-P
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.